Advertisement
Advertisement

BHVN

BHVN logo

Biohaven Ltd.

9.86
USD
Sponsored
+0.12
+1.23%
May 08, 16:00 UTC -4
Closed
exchange

After-Market

9.72

-0.13
-1.37%

Biohaven Ltd. Profile

About

Biohaven Ltd. is a clinical-stage biopharmaceutical company. It focuses on discovering and developing therapies for patients with debilitating neurological and neuropsychiatric diseases principally in the United States. Biohaven Ltd., formerly known as BIOHAVEN PHARM, is based in New Haven, Connecticut.

Info & Links

CEO

Vlad Coric

Headquarters

215 CHURCH STREET
NEW HAVEN, CT 06510, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.biohaven.com

Auditor

Ernst & Young LLP

Share holders

51

Employees

274

Biohaven Ltd. Statistics

Valuation Measures

Market Capitalization2

1.46B

Enterprise Value

1.47B

Enterprise Value/EBITDA(ttm)

-2.00

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

23.94

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-688.89%

Return on Invested Capital(ttm)

-255.11%

Return on Assets(ttm)

-158.04%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-735.46M

Net Income Available to Common(ttm)

-738.82M

Diluted EPS(ttm)

-6.96

Share Statistics

Beta (5Y Monthly)

1.34

52-Week Change

-51.31%

S&P 500 52-Week Change

26.60%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

150.42M

Dividend Yield

0.00%

Float4

129.66M

% Held by Insiders

13.80%

% Held by Institutions

88.78%

Balance Sheet

Total Cash(mrq)

319.14M

Total Cash Per Share(mrq)

2.12

Total Debt(mrq)

238.90M

Total Debt/Equity(mrq)

458.79%

Current Ratio(mrq)

3.18%

Quick Ratio(mrq)

3.18%

Book Value Per Share(mrq)

0.39

Cash Flow

Operating Cash Flow Per Share(ytd)

-5.66

Free Cash Flow(ytd)

-610.15M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement